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Continuous Photochemistry: The Flow Synthesis of Ibuprofen via a 
Photo-Favorskii Rearrangement  
M. Baumann,
a
 Ian R. Baxendale
a,
*
A new enabling technology for performing photochemical 
reactions in a continuous fashion is presented. This photo-reactor 
is compatible with existing flow systems and can be furthermore 
linked to a photo-spectrometer in order to allow for real time 
analysis of photochemical reactions. In this communication we 
wish to report the profiling of this system and its application to 
the continuous synthesis of ibuprofen based on a photo-Favorskii 
rearrangement reaction of a readily available α-
chloropropiophenone precursor. 
 
Due to its many benefits over conventional batch methods, 
flow chemistry has seen widespread applications in modern 
synthetic chemistry in areas such as synthesis methodology 
[1], material science [2] or the efficient preparation of bio-
active target compounds [3]. Specifically the latter area has 
witnessed great attention from academia as well as 
pharmaceutical and agrochemical industries as it provided a 
fertile ground for validating claims of safer and more efficient 
processing. This area has been reviewed recently summarizing 
the current standing of the community regarding the 
continuous manufacture of active pharmaceutical ingredients 
(API’s) and highlighting numerous accomplishments in this fast 
developing field [4]. Despite these milestones further efforts 
are needed in order to improve the overall processes by 
increasing the material throughput of such continuous 
approaches and at the same time utilising more atom 
economical and environmentally benign strategies. 
Consequently, recent focus has shifted towards the application 
of alternative continuous methods, for instance those based 
on electro- [5] and photochemical protocols [6]. In this article 
we wish to report on our results leading to a continuous 
synthesis of the high volume drug ibuprofen utilising a photo-
Favorskii rearrangement as the key step. 
Ibuprofen (1, isobutylphenyl propionic acid) is a nonsteroidal 
anti-inflammatory drug (NSAID) widely used for alleviating 
pain, fever and inflammation. It is sold over the counter and 
annual production is estimated to surpass 9.8 kilotonnes [7]. 
Since its discovery in the early 1960’s several routes have been 
reported [8] also including two recent flow approaches by 
McQuade (2009) [9] and Jamison (2015) [10]. Although the 
latter were not intended to rival the known manufacturing 
routes regarding modern process metrics (productivity, 
reagent cost, waste removal etc.), these examples represent 
important proof of concept studies towards generating a 
simple, yet high demand API in a continuous fashion. Both flow 
approaches share the use of a Friedel-Crafts acylation between 
isobutylbenzene (3) and propionic acid activated in situ using 
excess triflic acid or propionyl chloride and AlCl3 (Scheme 1). A 
subsequent 1,2-aryl migration step is achieved through 
treatment of the intermediate propiophenone species with 
either PhI(OAc)2/trimethyl orthoformate (HC(OMe)3) or 
ICl/trimethyl orthoformate yielding after alkaline ester 
hydrolysis crude ibuprofen or its sodium salt. Whilst 
McQuade’s earlier ap-proach delivers 9 mg ibuprofen per 
minute (51% isolated yield), the improved strategy reported by 
the Jamison lab generates up to 135 mg ibuprofen Na-salt per 
minute (83% isolated yield). 
  
Scheme 1: Previous flow approaches towards ibuprofen. 
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We initiated our own studies by devising a synthetic strategy 
based on a photo-Favorskii rearrangement of α-halopropio-
phenones and related compounds [11] to directly furnish the 
desired arylpropionic acid scaffold present in ibuprofen. As 
such we prepared key building block 5 by a Friedel-Crafts 
acylation between isobutylbenzene and chloropropionyl 
chloride in the presence of AlCl3. Performing this reaction in 
batch yielded the desired product with high regioselectivity 
(>9:1 para:ortho) and yield in a straightforward fashion. 
Although the chloropropionyl chloride used in this step is on 
small scale more expensive than propionic acid itself, we 
deemed this rapid access into the desired building block more 
favourable as (1) no further functionalisation or functional 
group interconversion is needed and (2) chloropionyl chloride 
can be cheaply prepared by chlorination of readily available 
and biorenewable lactic acid through literature-known 
procedures [12].  
 Scheme 2: Photo-Favorskii approach towards ibuprofen. 
 
In order to study the interconversion of α-halopropiophenone 
5 into ibuprofen we decided to use a commercially available 
Vapourtec E-series flow system in conjunction with its UV-150 
photo-reactor. This system is ideally suited for exploratory 
studies as it accommodates the bespoke photo-reactor that 
can be operated at various temperatures via active cooling or 
heating scenarios (-5 – 80 °C). Furthermore, the power setting 
of its high intensity medium pressure metal halide lamp can be 
selected and easily adjusted by dimming (50-100% equivalent 
to 75 – 150 W) whilst several filters can be used in order to 
select a specific wavelength range. In order to evaluate these 
filters towards our intended application we used a portable 
ExemplarLS spectrometer that was readily connected to the 
photo-flow reactor set-up allowing us to record transmission 
spectra of the lamp as well as the selected filters (I-V) provided 
with the system (Figure 1). 
 
Figure 1: Photo-reactor set-up and components. 
 
Screening the different filters by passing water as solvent 
through the flow set-up at 50% power setting (80 W) indicated 
that filter I and III (Figure 2) would specifically remove 
wavelengths above 400 nm which we deemed desirable as 
blocking the infrared part of the light emitted by the lamp 
would also reduce the necessity to actively adjust the 
temperature of the reactor coil.  
 
Figure 2: Effect of filters I-V on lamp emission spectrum. 
 
In a further set of experiments we profiled filter III regarding 
its response towards different lamp power settings for either 
a) the reaction solvent alone (10 vol% water in acetone; green 
graph Fig. 3), b) solvent containing α-chloropropiophenone 
substrate 5 (0.1 M; red graph Fig. 3) or c) solvent with 
substrate 5 (0.1 M) and scavenger (propylene oxide, 2 vol%; 
blue graph Fig. 3). Plotting the integral of the emission signal at 
365 nm against the power setting (in 50-100% or 80-141 W) 
confirmed that the solvent as well as the scavenger barely 
absorb at this wavelength, whilst the substrate absorbs about 
50% of the emitted light. Furthermore, the reaction products 
do not seem to significantly absorb light of this wavelength 
either. 
  
 
 
 
 
 
 
Figu
re 3: 
Corr
elati
on between lamp power setting and relative emission at 365 
nm (filter III). 
 
After this initial profiling of the photo-reactor set-up we 
commenced our synthetic studies by subjecting substrate 5 
(0.1 M solutions) to a set of reaction conditions in an attempt 
to prepare the desired ibuprofen product (Scheme 2). As such 
we elected to use acetone/water (90:10 vol/vol) as a green 
solvent system that would convert the putative spirocyclic 
intermediate 6 directly into the acid form of ibuprofen. 
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Furthermore, we decided to add a small quantity of propylene 
oxide (2 vol%) to this solvent system to act as a scavenger for 
the hydrochloric acid formed in the process. Having defined 
these parameters we next studied a selection of reaction 
conditions as summarized in table 1. 
We quickly established that employing either no filter or filters 
II, IV or V was unfavourable to the reaction outcome as the 
heat generated by the lamp led to a significant temperature 
increase greater than 80 °C and consequently resulted in 
substantial by-product formation. On the other hand 
regulating the reactor temperature to between 30-35 °C, by 
active cooling with a stream of cold nitrogen, under the same 
conditions gave a cleaner reaction albeit at the cost of residual 
starting material (>20%). We also encountered 
defunctionalised propiophenone 7, which arises from an 
undesired Norrish type I fragmentation pathway (~15%). Next 
we utilised filters I and III exposing the reactor coil to almost 
monochromatic light of ~365 nm wave-length. Pleasingly, both 
filters resulted in a much cleaner conversion of 5 into 
ibuprofen 1 (with very small amounts of Norrish product 7) 
allowing the further optimisation of these conditions. For the 
proceeding optimisation study filter I was selected over filter 
III as it allowed for a higher power input at the same major 
wavelength (see Figure 2). Subsequently, it was established 
that a concentration of 0.1 M with 200 μL scavenger/10 mL 
solution was best, whilst a lower concentration (0.08 M) did 
not improve the reaction and a higher concentration resulted 
in more Norrish-I product formation (table 1, entries 3, 4, 5). 
 
 Table 1. Screening of reaction conditions for photo-Favorskii rearrangement step in flow (1 mmol scale, n.a. = not applicable). 
 
entry filter concentration / 
M [scavenger/ 
vol%] 
reactor 
temperature 
/ °C 
lamp 
power 
setting 
tRes / 
min 
1
H-NMR ratio 5 : 1 : 7 
(reactions in duplicate) 
productivity 
of 1 / 
mmol/h 
1 none, II, 
IV, V 
0.1 [2] 30 to >80 
or 30 
(cooled) 
80% 20 >90% conv., complex 
mixture, 
70-80% conv., cleaner 
reaction 
n.a. 
2 III 0.1 [2] 55 80% 40 15 : 73 : 12 1.10 
3 I 0.1 [2] 65 80% 40 2 : 86 : 12 1.29 
4 I 0.08 [2] 65 80% 40 4 : 85 : 11 1.28 
5 I 0.12 [2] 65 80% 40 5 : 78 : 17 1.17 
6 I 0.1 [2] 65 80% 30 4 : 84 : 12 1.68 
7 I 0.1 [2] 65 80% 20 3 : 84 : 13 2.52 
8 I 0.1 [2] 65 80% 15 7 : 81 : 12 3.65 
9 I 0.1 [2] 65 80% 10 18 : 70 : 12 4.20 
10 I 0.1 [2] 65 80% 7.5 37 : 53 : 10 4.77 
11 I 0.1 [2] 70 90% 10 18 : 68 : 14 4.08 
12 I 0.1 [2] 75 100% 10 14 : 73 : 13 4.38 
13 I 0.1 [2] 70 90% 7.5 32 : 57 : 11 5.13 
14 I 0.1 [2] 75 100% 7.5 27 : 63 : 13 5.67 
15 I 0.1 [1] 65 80% 15 10 : 75 : 15 3.38 
16 I 0.1 [3] 65 80% 15 7 : 81 : 12 3.65 
17 I 0.1 [2] 20 (cooled) 80% 15 13 : 62 : 25 2.79 
Next the residence time was optimised indicating that just 
over 15 minutes was sufficient to achieve almost complete 
conversion of substrate 5 producing ibuprofen in >80% (table 
1, entries 3, 6, 7, 8). Whilst it was established that lower 
residence times of 10 or 7.5 minutes would give diminished 
conversions, the overall productivity of ibuprofen would under 
these conditions be significantly higher (table 1, entries 9 and 
10). This effect can be further enhanced by increasing the lamp 
power setting from 80% to 90 or 100% resulting in an 
increased productivity of up to 5.67 mmol ibuprofen per hour 
but at the cost of incomplete conversion of starting material 5 
(table 1, entries 9 - 14). In addition, a higher amount of 
scavenger was not found to be beneficial, whilst less scavenger 
led to in-creased amounts of the Norrish-I product (table 1, 
entries 8, 15, 16). Finally, decreasing the reaction temperature 
from 65°C to 20°C was found to lead to lower conversion with 
more Norrish-I product (table 1, entries 8 and 17) indicating 
that the conditions of entry 8 would seem to balance best the 
substrate conversion and ibuprofen productivity.  
In order to further profile this transformation selected cases 
were evaluated at larger scales (10 mmol). As such using the 
conditions of entry 7 delivered ibuprofen in 76% isolated yield, 
whereas scale-up of entry 9 and 14 generated the target 
compound in 63% and 54% respectively thus showing good 
agreement with the findings of the initial optimisation study. 
Besides the ease of performing this photo-Favorskii reaction in 
a continuous fashion, it was found that product isolation 
through solvent evaporation and acid-base extraction rapidly 
and reliably yielded ibuprofen upon trituration from hexanes 
as a white solid. 
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Conclusions 
In conclusion, we have developed a fast and efficient 
continuous process yielding ibuprofen via a photo-Favorskii 
rearrangement of a readily available α-chloropropiophenone 
precursor. Importantly, this has been achieved through a 
newly available enabling technology in the form of a 
photochemical reactor unit that can be used in combination 
with existing and commercially available flow reactor systems. 
Aided by real-time analysis through a small footprint photo-
spectrometer a rapid profiling of various reaction conditions 
(including different filters, residence times, concentrations 
etc.) was conducted, establishing conditions for high 
productivity of ibuprofen. The best conditions were 
subsequently verified at larger scale allowing photochemical 
production of multi-gram quantities of ibuprofen within a 
single working day. This demonstrates that this new 
photochemical reactor can be used efficiently for the 
continuous lab scale synthesis of valuable compounds.   
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